news
Zoledronic acid could be used to treat basal-like breast cancer
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer...
List view / Grid view
Drug Targets
news
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
news
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
news
Denosumab reduces glucocorticoid-induced bone loss
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients...
news
MS drug could reduce painful side effects of common cancer treatment
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib...
news
Experimental arthritis drug prevents stem cell transplant complication
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants...
news
New uses for existing antiviral drugs
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses...
news
Anticholinergic medications linked to dementia
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
news
Hemp shows potential for treating ovarian cancer
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
news
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
news
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
news
KL1333 receives FDA ODD for mitochondrial diseases
NeuroVive Pharmaceutical AB has been granted Orphan Drug Designation for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases...
news
Delivering cancer treatment on a nanodisc helps eliminate tumours
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice...
news
Could statins ease deadly heart condition in rare neuromuscular disease?
Penn study shows that cholesterol drug may help Friedreich's ataxia patients...
news
Diabetes drug may not reduce risk of death
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
